title: Bevacizumab in advanced lung cancer: in search of the right drug for the right patient.
authors.affiliation: Department of Oncology, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.
authors.forename: Timothy F
authors.initials: TF
authors.lastname: Burns
authors.forename: Rosalyn A
authors.initials: RA
authors.lastname: Juergens
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D057285:Precision Medicine; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab